| Net Income Per Share |
Net Income Per Share A reconciliation of net income available to common stockholders and the number of shares in the calculation of basic and diluted earnings per share was calculated as follows: | | | | | | | | | | | | | | | | | | | | | | | | | For the Three Months Ended September 30, | | For the Nine Months Ended September 30, | | (Dollars in thousands, except for share and per share amounts) | 2026 | | 2025 | | 2026 | | 2025 | | Net income attributable to Privia Health Group, Inc. common stockholders | $ | 13,487 | | | $ | 6,861 | | | $ | 25,599 | | | $ | 13,768 | | | Weighted-average common shares outstanding - basic | 127,535,114 | | | 122,768,890 | | | 125,948,746 | | | 121,840,638 | | | Weighted-average common share outstanding - diluted | 132,709,953 | | | 128,776,684 | | | 131,860,730 | | | 128,392,315 | | | Earnings per share attributable to Privia Health Group, Inc. common stockholders – basic | $ | 0.11 | | | $ | 0.06 | | | $ | 0.20 | | | $ | 0.11 | | | Earnings per share attributable to Privia Health Group, Inc. common stockholders – diluted | $ | 0.10 | | | $ | 0.05 | | | $ | 0.19 | | | $ | 0.11 | |
Below are the weighted-average diluted shares outstanding that were excluded from the computation of diluted earnings per share attributable to common stockholders for the period presented because they were anti-dilutive: | | | | | | | | | | | | | Nine Months Ended September 30, | | 2026 | | 2025 | | Weighted-average antidilutive shares outstanding | 2,818,604 | | | 3,914,853 | |
|